COVID-19 - February 7, 2022
COVID-19 vaccine-induced protection wanes at different speed
The vaccine-induced protection against SARS-CoV-2 infection wanes within a couple of months, but at different speed according to vaccine type, reports scientists from Umeå University. However, protection against severe COVID-19 appears to be better maintained. This is shown in a nationwide, registry-based study performed by researchers at Umeå University that now is published in The […]
COVID-19 - January 31, 2022
BerGenBio’s bemcentinib will be studied in the EU-SolidAct trial
BerGenBio and Oslo University Hospital have announced the execution of a collaborative agreement to study the BerGenBio AXL inhibitor bemcentinib, in hospitalised COVID-19 patients. The EU-SolidAct trial – European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial – is part of EU-RESPONSE, a pan-European research project involved with the rapid and coordinated […]
COVID-19 - January 19, 2022
Research shows persistent T cell response to omicron after infection and vaccination
A new study from Karolinska Institutet shows that T cells still recognize omicron after infection with previous variants of SARS-CoV-2 or vaccination. The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2. However, T cells still recognize omicron, the scientists report in a study published in […]
COVID-19 - January 19, 2022
COVID-19 smell and taste loss may have genetic link
Scientists have identified some genetic variants in people that may more likely lose their ability to taste and smell. The study, published in Nature Genetics, investigated nearly 70,000 adults with COVID-19 and found that persons with certain genetic tweaks on chromosome 4 were 11 percent more likely to lose the ability to smell and taste […]
COVID-19 - January 19, 2022
First subject dosed with Nykode’s vaccine candidate
Nykode Therapeutics has announced that the first subject has been dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate in its VB-D-01 Phase 1/2 trial. The T cell specific vaccine is designed to prime T cells, potentially generating a broad immune response against current and future variants. The VB-D-01 trial is a two-arm, open […]
COVID-19 - January 14, 2022
Protective gene variant against COVID-19 discovered
An international metastudy led by researchers at Karolinska Institutet has identified a specific gene variant that protects against severe COVID-19 infection. The researchers managed to pinpoint the variant by studying people of different ancestries, a feat they say highlights the importance of conducting clinical trials that include people of diverse descents. The results are published […]